Enterococcus-related vascular graft infection: A case series - 31/08/24
, Olivier Robineau a, b, Jonathan Sobocinski c, Piervito D’Elia d, Anne Boucher a, Barthelemy Lafon-Desmurs a, Macha Tetart a, Agnes Meybeck a, Pierre Patoz e, Eric Senneville a, bHighlights |
• | Vascular graft infection is commonly enterococcus-related. |
• | Enterococci are frequently involved in polymicrobial vascular graft infections. |
• | Fluoroquinolones resulted in clinical cure in most cases of enterococcal vascular graft infections. |
Abstract |
Objectives |
We aimed to assess the frequency, management, and burden of enterococcal-related vascular graft infection.
Patients and methods |
From 2008 to 2021, data regarding all episodes of vascular graft infections initially managed or secondarily referred to our referral center were prospectively collected. We described the history and management of the infection, depending on the type of prosthesis used.
Results |
The frequency of enterococcal-related vascular graft infections was 29/249 (12 %). Most of them were early infections (22/29, 76 %). Infections were polymicrobial (26/29, 90 %), mostly associated with Enterobacterales. Among patients with positive blood cultures, 7/8 (88 %) involved enterococci. Patients with enterococcal-related vascular graft infections were mainly (22/29, 76 %) treated with an association of antibiotics. Mortality and relapse occurred in 28 % and 7 % respectively of the cases.
Conclusions |
Enterococcal-related vascular graft infections occurred in patients with comorbidities, during the early period following surgery and were more frequent in cases of intra-cavitary prosthesis. Their potential virulence needs to be considered, especially in polymicrobial infections.
Le texte complet de cet article est disponible en PDF.Keywords : Enterococcus spp., Fluoroquinolone, Polymicrobial, Prosthetic vascular infection, Rifampicin
Plan
Vol 54 - N° 6
Article 104940- septembre 2024 Retour au numéro
Article précédent
- Tick-borne diseases at the crossroads of the Middle East and central Europe
- Pavle Banović, Dejan Jakimovski, Ivana Bogdan, Verica Simin, Dragana Mijatović, Mile Bosilkovski, Sofija Mateska, Adrian A. Díaz-Sánchez, Angelique Foucault-Simonin, Zbigniew Zając, Jaonna Kulisz, Sara Moutailler, Alejandro Cabezas-Cruz
- Tumor necrosis factor-alpha antagonists in patients with complicated spinal tuberculosis: A case series and literature review
- Aayesha J. Soni, Yashvir Rugbeer, Julius Rozmiarek, Abi Manesh, Suzaan Marais
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?